Consumer staples stocks are soaring in 2026. Kimberly-Clark is discounted compared to the broader sector.

Kimberly-Clark Corporation (KMB) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

DALLAS, Feb. 19, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today presented at the 2026 Consumer Analyst Group of New York (CAGNY) Conference, outlining how Kimberly-Clark's fast and agile operating model and differentiated capabilities position the company to benefit from growth trends in key cohorts, raise the standard of care and create generational value through its pending acquisition of Kenvue. "For more than 150 years, Kimberly-Clark has been there for people at their most important moments, with consumer-inspired innovation that creates deep connections through the essential stages of their lives," said Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark.

Assetmark Inc. grew its stake in shares of Kimberly-Clark Corporation (NASDAQ: KMB) by 45.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,650 shares of the company's stock after acquiring an additional 7,069 shares during the period. Assetmark Inc.'s holdings

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring steps ahead of its planned combination with Kimberly-Clark. For Q4, Kenvue posted adjusted earnings per share of $0.27, beating analyst estimates of $0.22.

Vanguard Group Inc. boosted its holdings in Kimberly-Clark Corporation (NASDAQ: KMB) by 0.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 40,530,753 shares of the company's stock after acquiring an additional 95,277 shares during the period. Vanguard Group Inc. owned

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring...

The job cuts are part of a restructuring plan to optimize its operating model and drive operational efficiencies, the company said.

Tylenol-maker Kenvue on Tuesday beat Wall Street estimates for fourth-quarter results and announced a global workforce reduction, as it proceeds toward a planned takeover by Kimberly-Clark.

February's 5 Dividend Growth Stocks With Yields Up To 8.05%